Orchestra BioMed Holdings, Inc. (OBIO) Balance Sheet
As of 2026-06-30 (10-Q), Orchestra BioMed Holdings, Inc. (OBIO) reported total assets of $115.7M, total liabilities of $86.3M and shareholders' equity of $19.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $20.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OBIOOrchestra BioMed Holdings, Inc.Follow OBIO — free
—
Price chart with a free account
- Market cap
- 336.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.0 | 1.8 | 19.8 | 30.6 | 22.3 | 34.7 | 20.5 | |
| Short-term investments | — | — | 63.9 | 57.0 | 44.6 | 71.8 | 89.5 | |
| Receivables | — | — | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Inventory | — | — | 0.3 | 0.1 | 0.2 | 0.3 | 0.3 | |
| Current assets | 2.1 | 1.8 | 84.7 | 89.1 | 69.2 | 107.9 | 111.2 | |
| Total assets | 162.2 | 161.8 | 95.6 | 95.2 | 76.2 | 114.9 | 115.7 | |
| Current liabilities | 0.1 | 0.2 | 18.6 | 11.2 | 16.2 | 16.7 | 13.5 | |
| Long-term debt | — | — | — | — | 15.0 | 15.0 | — | |
| Total liabilities | 5.7 | 5.8 | 43.0 | 27.2 | 43.2 | 51.5 | 86.3 | |
| Shareholders' equity | -3.6 | -19.8 | 52.5 | 68.0 | 33.0 | 53.6 | 19.3 |
USD millions · SEC XBRL
Orchestra BioMed Holdings, Inc. — questions
- How much cash does Orchestra BioMed Holdings, Inc. have?
- $20.5M in cash and cash equivalents as of 2026-06-30.
- What are Orchestra BioMed Holdings, Inc.'s total assets?
- $115.7M as of 2026-06-30.
- What is Orchestra BioMed Holdings, Inc.'s shareholders' equity?
- $19.3M as of 2026-06-30.
Every figure on this page comes from Orchestra BioMed Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.